NO176317C - Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede - Google Patents
Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjedeInfo
- Publication number
- NO176317C NO176317C NO882516A NO882516A NO176317C NO 176317 C NO176317 C NO 176317C NO 882516 A NO882516 A NO 882516A NO 882516 A NO882516 A NO 882516A NO 176317 C NO176317 C NO 176317C
- Authority
- NO
- Norway
- Prior art keywords
- acetic acid
- side chain
- acid derivatives
- therapeutically active
- benzothiazole
- Prior art date
Links
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001242 acetic acid derivatives Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 235000011054 acetic acid Nutrition 0.000 abstract 1
- 150000001243 acetic acids Chemical class 0.000 abstract 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002168 ethanoic acid esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5989987A | 1987-06-09 | 1987-06-09 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO882516D0 NO882516D0 (no) | 1988-06-08 |
| NO882516L NO882516L (no) | 1988-12-12 |
| NO176317B NO176317B (no) | 1994-12-05 |
| NO176317C true NO176317C (no) | 1995-03-15 |
Family
ID=22026001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO882516A NO176317C (no) | 1987-06-09 | 1988-06-08 | Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0295051B1 (cs) |
| JP (1) | JPH0676391B2 (cs) |
| KR (1) | KR900004698B1 (cs) |
| CN (1) | CN1024347C (cs) |
| AT (1) | ATE90347T1 (cs) |
| AU (1) | AU593742B2 (cs) |
| CA (1) | CA1321791C (cs) |
| CS (1) | CS274628B2 (cs) |
| DD (3) | DD280320A5 (cs) |
| DE (1) | DE3881583T2 (cs) |
| DK (1) | DK309988A (cs) |
| EG (1) | EG18613A (cs) |
| ES (1) | ES2040853T3 (cs) |
| FI (1) | FI93835C (cs) |
| HU (1) | HU205108B (cs) |
| IE (1) | IE61499B1 (cs) |
| IL (1) | IL86660A0 (cs) |
| MY (1) | MY103573A (cs) |
| NO (1) | NO176317C (cs) |
| NZ (1) | NZ224937A (cs) |
| PH (1) | PH25928A (cs) |
| PL (1) | PL157690B1 (cs) |
| PT (1) | PT87669B (cs) |
| SU (1) | SU1678208A3 (cs) |
| YU (1) | YU46696B (cs) |
| ZA (1) | ZA884075B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
| WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
| US4904782A (en) * | 1988-02-29 | 1990-02-27 | Pfizer Inc. | Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate |
| US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
| US5304557A (en) * | 1989-12-15 | 1994-04-19 | Pfizer Inc. | Substituted oxoophthalazinyl acetic acids and analogs thereof |
| US5064830A (en) * | 1990-08-02 | 1991-11-12 | Pfizer Inc. | Lowering of blood uric acid levels |
| WO1992003432A1 (en) * | 1990-08-28 | 1992-03-05 | Pfizer Inc. | 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate |
| DE9290035U1 (de) * | 1991-03-28 | 1993-11-18 | Pfizer Inc., New York, N.Y. | Pyridazinonessigsäuren |
| FR2682108B1 (fr) * | 1991-10-07 | 1994-01-07 | Lipha | Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant. |
| DE69405193T2 (de) * | 1993-10-06 | 1998-01-02 | Sumika Fine Chemicals Co Ltd | Verfahren zur Herstellung von Alkyl-3-phthalidylidenacetat |
| US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
| IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
| EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
| SG82702A1 (en) * | 1999-09-28 | 2001-08-21 | Ebauchesfabrik Eta Ag | Timepiece including a movement mounted in a casing ring |
| CN116970317B (zh) * | 2023-03-20 | 2024-06-25 | 安徽庆丰涂料科技有限公司 | 可呼吸的负离子抗菌涂料及其加工工艺 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| JPS5931509B2 (ja) * | 1979-06-06 | 1984-08-02 | 昭和電工株式会社 | ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法 |
| DE3684410D1 (de) * | 1985-11-07 | 1992-04-23 | Pfizer | Heterocyclische oxophthalazinylessigsaeure. |
-
1988
- 1988-06-02 JP JP63136601A patent/JPH0676391B2/ja not_active Expired - Lifetime
- 1988-06-06 PH PH37013A patent/PH25928A/en unknown
- 1988-06-06 MY MYPI88000606A patent/MY103573A/en unknown
- 1988-06-07 DD DD88326849A patent/DD280320A5/de not_active IP Right Cessation
- 1988-06-07 ES ES198888305180T patent/ES2040853T3/es not_active Expired - Lifetime
- 1988-06-07 EP EP88305180A patent/EP0295051B1/en not_active Expired - Lifetime
- 1988-06-07 AT AT88305180T patent/ATE90347T1/de not_active IP Right Cessation
- 1988-06-07 DD DD88326850A patent/DD280323A5/de not_active IP Right Cessation
- 1988-06-07 CS CS392488A patent/CS274628B2/cs not_active IP Right Cessation
- 1988-06-07 DE DE8888305180T patent/DE3881583T2/de not_active Expired - Fee Related
- 1988-06-07 DD DD88316492A patent/DD281600A5/de not_active IP Right Cessation
- 1988-06-07 PL PL1988272899A patent/PL157690B1/pl unknown
- 1988-06-07 CA CA000568775A patent/CA1321791C/en not_active Expired - Fee Related
- 1988-06-08 FI FI882722A patent/FI93835C/fi not_active IP Right Cessation
- 1988-06-08 CN CN88103507A patent/CN1024347C/zh not_active Expired - Fee Related
- 1988-06-08 NZ NZ224937A patent/NZ224937A/xx unknown
- 1988-06-08 HU HU882971A patent/HU205108B/hu not_active IP Right Cessation
- 1988-06-08 YU YU111188A patent/YU46696B/sh unknown
- 1988-06-08 IL IL86660A patent/IL86660A0/xx not_active IP Right Cessation
- 1988-06-08 NO NO882516A patent/NO176317C/no not_active IP Right Cessation
- 1988-06-08 ZA ZA884075A patent/ZA884075B/xx unknown
- 1988-06-08 SU SU884355901A patent/SU1678208A3/ru active
- 1988-06-08 KR KR1019880006855A patent/KR900004698B1/ko not_active Expired
- 1988-06-08 AU AU17491/88A patent/AU593742B2/en not_active Ceased
- 1988-06-08 PT PT87669A patent/PT87669B/pt not_active IP Right Cessation
- 1988-06-08 IE IE171688A patent/IE61499B1/en unknown
- 1988-06-08 DK DK309988A patent/DK309988A/da not_active Application Discontinuation
- 1988-06-09 EG EG320/88A patent/EG18613A/xx active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176317C (no) | Fremgangsmåte for fremstilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede | |
| NO175371C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater | |
| FI880757A0 (fi) | Menetelmä valmistaa terapeuttisesti vaikuttavia tyydytettyjä heterosyklisiä karboksamidijohdoksia | |
| NO174043C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mettede fettsyreamider | |
| FI875666A0 (fi) | Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi | |
| ATE74346T1 (de) | Alkensaeurederivate. | |
| FI890723A0 (fi) | Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi | |
| FI903626A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisen 1H-indatsoli-3-etikkahappojohdannaisen valmistamiseksi | |
| IL87429A0 (en) | A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives | |
| AU605754B2 (en) | Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids | |
| FI896284A7 (fi) | Menetelmä karboksyylihappojohdannaisten valmistamiseksi | |
| NO890815D0 (no) | Fremgangsmaate for fremstilling av ftalazineddiksyreester-derivater. | |
| EP0334598A3 (en) | Synthesis of 2-(4'aminophenoxy) alkanoic acids and esters and their derivatives | |
| NO171275C (no) | Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika | |
| NO174346C (no) | Fremgangsmåte for fremstilling av 5-aroyl-1,2-dihydro-3H-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav | |
| ES2038335T3 (es) | Procedimiento para preparar mezclas e/z de derivados de acido 2-(biciclo(3.3.0)octan-3-iliden)-acetico con porcion predominante de e o de z. | |
| FI895795A0 (fi) | Menetelmä optisesti aktiivisten 2-oksoimidatsolidiinijohdannaisten valmistamiseksi | |
| IL102576A0 (en) | Process for the production of phthalazineacetic acid ester derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN DECEMBER 2001 |